Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recentonset type 1 diabetes: A randomized double-blind trial

D. K. Wherrett, B. Bundy, D. J. Becker, L. A. DiMeglio, S. E. Gitelman, R. Goland, P. A. Gottlieb, C. J. Greenbaum, K. C. Herold, J. B. Marks, R. Monzavi, A. Moran, T. Orban, J. P. Palmer, Philip Raskin, H. Rodriguez, D. Schatz, D. M. Wilson, J. P. Krischer, J. S. Skyler

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)S115-S116
JournalDiabetes Technology and Therapeutics
Issue numberSUPPL.1
StatePublished - Jun 1 2013

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medical Laboratory Technology

Cite this